Articles tagged with Cell Responses
Assistant professor David Knowles at Columbia University wins a $500,000 NSF CAREER Award to develop a new framework and tools for analyzing alternative splicing in diseases such as ALS and cancer. The project aims to create more accurate algorithms for single-cell and long-read RNA-seq analysis.
Researchers found a 1000-fold increase in skin microbiota and larger lesions after smallpox vaccination, but all groups had equal protection from re-infection. The study suggests that manipulating commensal skin microbiota might enhance the efficacy of intradermal vaccines.
A new study found that microglia regulate neuronal subtypes differently in response to bacteria, affecting intrinsic excitability. Pyramidal cells exhibited lower excitability, while Purkinje cells showed higher excitability when modulated by microglia.
A study by Tokyo University of Science researchers has demonstrated that a computationally-light model can simulate complex brain cell responses, including periodic and quasi-periodic responses. The Izhikevich neuron model was found to be capable of reproducing both types of responses at lower computational cost.
Researchers developed a new treatment option for relapsed or refractory CD30+ lymphoma using natural killer cells complexed with a CD30/CD16A bispecific antibody. The treatment showed an overall response rate of 89% in patients with advanced lymphoma.
Scientists at Johannes Gutenberg University discovered that fruit fly eyes can distinguish six types of global motion patterns generated by self-motion. The T4/T5 cell subtypes directly represent complex motion cues rather than uniform directions, matching the fly's actual behavior closely.
New research suggests the brain uses multiple strategies to process smells, employing both snapshot-like and evolving ensemble approaches. The study provides new tools for scientists to quantify and interpret brain activity patterns.
Dendritic cells, or 'sentinel' immune cells, are vital to maintaining the body's immune balance. Researchers have discovered their essential role in treating cancer and severe viral infections by preventing immunopathology.
Researchers at Kobe University discover that immobilization induces loss of muscle mass by disrupting calcium levels and triggering the KLF15-IL-6 pathway. This finding may lead to the development of a treatment for muscle loss, known as sarcopenia, which affects aging societies.
A new study reveals that intra-tumoral injections of a plant virus-based immunotherapy could lead to groundbreaking therapy for both canine and human inflammatory breast cancer patients. The treatment generated potent local and systemic anti-tumor immune responses, improving quality of life and survival in treated dogs.
Researchers at Flinders University have developed a novel approach to modify nano-particles' surface chemistry to tailor the body's immune response. This technique shows promise for safer, more effective vaccines, drug delivery, and disease diagnostics and treatments.
Scientists from the Institute of Industrial Science have developed a theoretical model for optimal search strategy in biological systems, which may help design new drones or nanobots. The model uses stochastic optimal control theory to analyze chemotaxis, a process of attraction to chemical gradients.
Researchers at UC San Diego have made a groundbreaking discovery about the role of fibroblasts, or fat cells, in controlling bacteria and developing acne. These findings could lead to more targeted treatment options for acne, which affects up to 50 million Americans each year.
Researchers identified three KCTD proteins that modulate neurotransmitter activity, enabling fine-tuned movement. Their elimination enhances cAMP production and sensitivity to dopamine in neurons.
Scientists at Technical University of Munich discovered a promising combination therapy for mesenchymal PDAC subtype, showing improved T-cell infiltration and cell cycle arrest when using nintedanib with trametinib. The treatment significantly improves the response of highly aggressive mesenchymal PDAC subtypes in mice.
Researchers at TUM discover that intestinal bacteria interact with Paneth cells in the gut mucus layer, leading to chronic inflammation. This finding may lead to new treatments for IBD.
Researchers at RIKEN have developed a new retinal transplant technique by engineering human-derived retina sheets to lose bipolar cells, allowing better connections to host retinas and improved responses to light. The technique has shown substantial functional improvement in animal studies and is now poised for human clinical trials.
A new study reveals that the Omicron variant is sensitive to inhibition by the interferon response, an unspecific immune reaction present in all body cells. This provides the first explanation for why COVID-19 patients infected with Omicron are less likely to experience severe disease.
Researchers found that pig cells undergo apoptosis at a higher rate than human cells in response to SARS-CoV-2 infection, helping to limit viral replication and avoid severe illness. This discovery could lead to therapies designed to trigger apoptosis in human cells, reducing the severity of COVID-19 symptoms.
A study published in MBio found that removing the NS2 protein from Respiratory Syncytial Virus (RSV) allows the human body's immune response to destroy the virus before exaggerated inflammation begins. This discovery could lead to new therapeutics targeting this protein for other respiratory viruses like influenza A and SARS-CoV-2.
Northwestern University scientists have identified a key mechanism used by the Zika virus to evade the antiviral response of host cells. The study reveals how the virus suppresses interferon signaling to gain access to cells, providing a new target for antiviral therapeutics.
Researchers at Trinity College Dublin have identified a crucial protein, myeloid cell nuclear differentiation antigen (MNDA), that regulates type I interferon production in response to viral infections. This breakthrough discovery has significant implications for the development of new therapies to boost or suppress immune responses, p...
Researchers developed an injectable, adhesive surgical gel that prevents postoperative adhesions and improves wound healing. The gel, dubbed HAD, was tested in rats and rabbits with promising results, showing a significant reduction in inflammation and mortality rates.
A new study reveals that mRNA vaccines activate a type of helper cell called T follicular helper cells, which assist in creating powerful antibodies and drive the development of immune memory. This strong response helps prevent severe disease and death, even against highly mutated variants like omicron.
A University of California, Riverside study found that diet impacts taste sensitivity and food choice in fruit flies, using macronutrients like sugars and amino acids for survival. Flies adjusted their taste preferences based on dietary imbalances, influencing food choices to regain a balanced diet.
Researchers identified three prototypical RNA-expression states in pancreatic cancer cells and found that altering the tumor microenvironment can drive tumor cells to become more susceptible to certain drugs. This discovery opens up new possibilities for personalized medicine and targeting specific drug responses.
Researchers at the University of Oklahoma have discovered a new protein fragment that could improve cartilage regeneration and reduce the need for osteoarthritis treatments. The protein fragment, developed by Handan Acar and Amgad Haleem, aims to help the body heal itself by elicititing a response from stem cells.
Researchers discovered that pregnancy triggers the activation of Natural Killer T (NKT) cells to prevent breast cancer. After pregnancy, breast epithelial cells produce a specific protein called CD1d, which attracts NKT cells to monitor and eliminate potential cancer cells.
A recent study in mice has uncovered a protein called BMI-1 that gets turned on too early in B cells during chronic viral infection, resulting in low-quality antibodies. Targeting this protein can change the nature of the B cell to produce higher quality antibodies, potentially providing a new therapeutic pathway.
Antibodies that mimic the SARS-CoV-2 virus may explain lingering symptoms of long-haul COVID-19 and rare vaccine side effects like allergic reactions and blood-clotting. This theory, based on classic immunological concepts, suggests a cascade of immune responses that can lead to adverse effects.
Scientists discovered an important protective response in the heart that can prevent excessive scarring after a heart attack. The study found that this reactive response can limit cardiac fibrosis by preventing oxidant build-up in heart cells, potentially leading to new therapies to repair scarring damage.
A Johns Hopkins-led study found that leptin cancels out the effects of Tamoxifen, making it ineffective for obese patients with breast cancer. Researchers suggest that interventions targeting leptin or Med1 may improve Tamoxifen's success in this group.
Researchers developed a blood test that can detect prostate cancer patients who are resistant to chemotherapy drug docetaxel, enabling early detection and personalized treatment. The test analyzes circulating tumor cells in the bloodstream, revealing patterns that predict disease progression and survival.
Researchers at Mount Sinai have developed a diverse library of well-characterized human induced pluripotent stem cell lines from clinically healthy individuals, offering valuable resources for studying normal human biology, evaluating drug responses, and disease modeling.
Scientists from the University of Johannesburg found that shining two lasers on adult stem cells accelerates their transformation into different types of cells. The consecutive irradiation increases proliferation and differentiation under laboratory conditions, paving the way for potential therapies to repair damaged tissues.
Researchers will focus on understanding the disease, identifying B cell characteristics and plasma cells that create attacking antibodies. The study aims to enhance knowledge of SLE pathogenesis and differences in clinical manifestations, outcomes, and therapeutic responses.
The research team aims to understand the mechanisms that contribute to long-term consequences of COVID-19 infection, particularly in women who may be disproportionally affected by chronic symptoms. They plan to leverage a biorepository and longitudinal study to assess the impact of acute and chronic inflammation on brain injury and neu...
Researchers analyzed the effects of small-molecule drugs on colorectal tumor cells, finding that treatment with Imipridones decreased certain cytokines and increased others. The study highlights the complexity of cytokine signaling and its potential as a biomarker for diagnosis and prognosis in colon cancer.
A new study from the University of Gothenburg introduces an AI-based method to develop faster, cheaper, and more reliable information about cells using microscopy. This approach eliminates the drawbacks of traditional fluorescence microscopy by providing accurate results without damaging cells or inhibiting processes.
Researchers from FAU and MIT develop a microfluidic assay to study the mechanical performance of red blood cells under hypoxic conditions. The study reveals that cyclic hypoxia can lead to mechanical degradation of the red blood cell membrane, contributing to aging.
Researchers investigated antibody response to Pfizer-BioNTech vaccine in 117 allogeneic hematopoietic stem cell transplant recipients. The study aimed to assess vaccine safety and immune response in this population. Key findings were not reported in the article.
Researchers found that a family of proteins enhances the immune response to HIV, Ebola and Zika by boosting signals sent within immune cells. This discovery has implications for potential broad antiviral therapy.
Researchers at UC San Diego will use $6.4 million in NIH funding to study the influence of external signals on insulin production in beta cells. They aim to create a roadmap of genetic variations that can predict changes in insulin output, which may help prevent and treat diabetes.
Researchers analyzed plasma and single immune cells from nearly 200 COVID-19 patients and found metabolic changes associated with disease severity. The study's findings could lead to better therapies targeting immune-metabolic changes in severe disease cases.
A comprehensive review reveals how excessive fructose intake can disrupt metabolic pathways, leading to diseases such as diabetes, fatty liver disease, and heart disease. The study highlights the role of protein transporters, gluconeogenesis, and gene-level changes in regulating fructose metabolism.
Researchers at the University of Würzburg have found that innate lymphoid cells can specialize into killer cells that recognize and kill tumour cells. The study reveals a new transcription factor, Hobit, drives this specialization process.
Researchers at Karolinska Institutet discovered three different subtypes of mature fat cells in white adipose tissue, with only one subtype, Adipo PLIN, responding to insulin. The study suggests that changes in this specific subtype may contribute to metabolic diseases like Type 2 diabetes.
A new droplet digital PCR-based assay for HPV16 circulating tumor DNA was developed to predict treatment response in metastatic head and neck squamous cell carcinoma. Longitudinal changes of HPV16 ctDNA correlate with treatment response, allowing for early identification of treatment failure.
Scientists have discovered how neurotransmitters and proteins interact to trigger neuronal responses in the brain, with implications for understanding mood disorders and addictions. The study reveals small changes in protein connections control cellular responses, enabling precise regulation of neurotransmitter effects.
A recent study by Queen Mary University of London provides new insight into the mechanisms behind uncontrolled inflammation in COVID-19 patients. The research found that treatments increasing specialised pro-resolving mediators (SPM) production, such as dexamethasone, may play a key role in limiting disease severity.
Researchers found that patients who developed severe COVID-19 had a muted antiviral response in cells collected from nasal swabs at the time of diagnosis. This early response may determine the course of disease, opening up new avenues for interventions to prevent severe disease.
Researchers found that severe COVID-19 patients have muted interferon responses, leading to a failed early immune response. The study suggests that building on type I interferon may be key to developing treatments for severe COVID-19.
Researchers developed a tapered fiber optoacoustic emitter (TFOE) for non-genetic photoacoustic neural stimulation at the single cell level. The technology achieves high spatial resolution and optoacoustic conversion efficiency, allowing for precise control over neuron activity patterns.
A single dose of the Sputnik V vaccine elicits significant antibody responses against SARS-CoV-2, with 94% of participants developing IgG antibodies within three weeks. Previously infected individuals show higher antibody levels after one dose compared to fully vaccinated volunteers.
Researchers identified an internal communication network in mammals that regulates tissue repair and inflammation. Endogenous retroviruses control this dialogue, affecting the host immune system and antimicrobial defenses.
A new device at the University of Exeter allows for more precise sorting and analysis of individual human cells based on their response to stimuli. This innovation has the potential to improve personalized medicine by detecting which drugs are likely to work for specific patients, reducing unnecessary side effects.
A team of researchers at Texas A&M University used experimental cellular evolution to study how cells respond to controlled mechanical properties. They found that cellular mechanosensing is not optimal but a tradeoff, and that cells can evolve under selection pressure from biomaterials of controlled stiffness.
Adaptimmune Therapeutics plc reports initial data from its Phase 2 SPEARHEAD-1 trial showing a high response rate of 41.4% for patients with synovial sarcoma, including two complete responses and encouraging initial safety and durability. The trial's results support the company's BLA submission next year.
Researchers at UCLA have identified six signaling codons that specific immune cells use to call up immune defense genes. These codon-words can lead to incorrect gene activation and cause autoimmune diseases like Sjögren's syndrome, which is found when the body mistakenly attacks itself.
A new study found that a single dose of the Pfizer or Moderna mRNA vaccine can stimulate an immune response in people who have previously recovered from COVID-19. The vaccine's ability to generate antibodies and B cell responses was shown to be effective against the South African variant.